Back to Search Start Over

Single-cell genomics and regulatory networks for 388 human brains.

Authors :
Emani PS
Liu JJ
Clarke D
Jensen M
Warrell J
Gupta C
Meng R
Lee CY
Xu S
Dursun C
Lou S
Chen Y
Chu Z
Galeev T
Hwang A
Li Y
Ni P
Zhou X
Bakken TE
Bendl J
Bicks L
Chatterjee T
Cheng L
Cheng Y
Dai Y
Duan Z
Flaherty M
Fullard JF
Gancz M
Garrido-Martín D
Gaynor-Gillett S
Grundman J
Hawken N
Henry E
Hoffman GE
Huang A
Jiang Y
Jin T
Jorstad NL
Kawaguchi R
Khullar S
Liu J
Liu J
Liu S
Ma S
Margolis M
Mazariegos S
Moore J
Moran JR
Nguyen E
Phalke N
Pjanic M
Pratt H
Quintero D
Rajagopalan AS
Riesenmy TR
Shedd N
Shi M
Spector M
Terwilliger R
Travaglini KJ
Wamsley B
Wang G
Xia Y
Xiao S
Yang AC
Zheng S
Gandal MJ
Lee D
Lein ES
Roussos P
Sestan N
Weng Z
White KP
Won H
Girgenti MJ
Zhang J
Wang D
Geschwind D
Gerstein M
Source :
BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 30. Date of Electronic Publication: 2024 Mar 30.
Publication Year :
2024

Abstract

Single-cell genomics is a powerful tool for studying heterogeneous tissues such as the brain. Yet, little is understood about how genetic variants influence cell-level gene expression. Addressing this, we uniformly processed single-nuclei, multi-omics datasets into a resource comprising >2.8M nuclei from the prefrontal cortex across 388 individuals. For 28 cell types, we assessed population-level variation in expression and chromatin across gene families and drug targets. We identified >550K cell-type-specific regulatory elements and >1.4M single-cell expression-quantitative-trait loci, which we used to build cell-type regulatory and cell-to-cell communication networks. These networks manifest cellular changes in aging and neuropsychiatric disorders. We further constructed an integrative model accurately imputing single-cell expression and simulating perturbations; the model prioritized ~250 disease-risk genes and drug targets with associated cell types.<br />Competing Interests: Competing interests Z. Weng (UMass Chan Medical School) co-founded and serves as a scientific advisor for Rgenta Inc. From April 11, 2022, N.L. Jorstad (Allen Institute for Brain Science) has been an employee of Genentech. K.P.W. (National University of Singapore) is a shareholder in Tempus AI and Provaxus Inc. The other authors declare no competing interests.

Details

Language :
English
ISSN :
2692-8205
Database :
MEDLINE
Journal :
BioRxiv : the preprint server for biology
Publication Type :
Academic Journal
Accession number :
38562822
Full Text :
https://doi.org/10.1101/2024.03.18.585576